Opko Health
OPK
199 hedge funds and large institutions have $259M invested in Opko Health in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 25 closing their positions.
48% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 25
29% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 49
6% more funds holding
Funds holding: 187 → 199 (+12)
2.58% more ownership
Funds ownership: 23.91% → 26.49% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $308M → $259M (-$48.6M)
56% less call options, than puts
Call options by funds: $3.23M | Put options by funds: $7.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.47M |
| 2 |
State Street
Boston,
Massachusetts
|
+$6.45M |
| 3 |
Morgan Stanley
New York
|
+$6.27M |
| 4 |
BlackRock
New York
|
+$4.76M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$2.41M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.39M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.34M |
| 4 |
JP Morgan Chase
New York
|
-$1.25M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$837K |
OPK Hedge Fund Activity: Q4 2019 in Review
199 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2019, worth a combined $259M — down 16% from $308M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new OPK positions and 25 closed out — a net gain of 12 holders — while 63 added to existing stakes and 49 trimmed.
The largest buyer was Vanguard Group, adding an estimated $6.47M. The largest seller was Oracle Investment Management, cutting an estimated $2.41M.
- 199 institutional investors held Opko Health (OPK) as of Q4 2019, up from 187 in Q3 2019.
- Funds reported $259M of Opko Health stock for Q4 2019, down 16% quarter-over-quarter.
- 37 funds opened new Opko Health positions in Q4 2019 and 25 closed out, a net change of +12 holders.
- The largest Opko Health buyer in Q4 2019 was Vanguard Group, an estimated $6.47M added.
- The largest Opko Health seller in Q4 2019 was Oracle Investment Management, an estimated $2.41M sold.
Based on aggregated 13F filings for Q4 2019.